Chemical Moieties/Peptide Mediated Options for Combating Corona Virus: A Review

Ajeet^1, , Babita Aggarwal² and Santosh Kumar Verma¹

¹Faculty of Pharmaceutical Sciences, Motherhood University, Roorkee, India

²School of Pharmacy, Vishveshwarya Group of Institutions, G. Noida, India

Cite this paper:
Ajeet, Babita Aggarwal and Santosh Kumar Verma. Chemical Moieties/Peptide Mediated Options for Combating Corona Virus: A Review. American Journal of Pharmacological Sciences. 2020; 8(1):7-8. doi: 10.12691/ajps-8-1-2

Abstract

The aim of this review is to understanding and finding the mode of a synthetic chemical molecule or peptide that could crack outbreak of human corona virus nCoV-19 (COVID-19) to some extent or you can say that selecting the best from what has been already tried. To fulfill this aim we started searching research / review article database of PUBMED. After comparing possible options of combating the problem, peptide intervention and synthetic moieties have been found that could break the outbreak of COVID-19.

Keywords:
corona virus Covid-19 protease ACE-2 pyrazolones

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Al-Hazmi A. Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences 2016; 23: 507–511. (http://dx.doi.org/10.1016/j.sjbs.2016.02.019)
[2]	Dörries R, Watanabe R, Wege H, ter Meulen V. nalysis of the intrathecal humoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM. J Neuroimmunol. 1987; 14(3): 305-316.
[3]	Guo JP, Petric M, Campbell W, McGeer PL. SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 2004; 324(2): 251-256.
[4]	Basak S, Hao X, Chen A, Chrétien M, Basak A. Structural and biochemical investigation of heptad repeat derived peptides of human SARS corona virus (hSARS-CoV) spike protein. Protein Peptide Letters 2008; 15(9): 874-886.
[5]	Lee YS, Park SM, Kim BH. Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. Bioorganic and Medicinal Chemistry Letters 2009; 19(4): 1126-1128.
[6]	Kumar KS, Ganguly S, Veerasamy R, De Clercq E. Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. European Journal of Medicinal Chemistry 2010; 45(11): 5474-5479.
[7]	Shah F, Mukherjee P, Desai P, Avery M. Computational Approaches for the Discovery of Cysteine Protease Inhibitors Against Malaria and SARS. Current Computer Aided Drug Design, 2010; 6: 1-23.
[8]	Kaparianos A, Argyropoulou E. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome. Current Medicinal Chemistry 2011; 18(23): 3506-3515.
[9]	Krishnan SK, Ganguly S, Veerasamy R, Jan B. Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones. European Review for Medical and Pharmacological Sciences 2011; 15(6): 673-681.
[10]	Kim MK, Yoon H, Barnard DL, Chong Y. Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives. Chem Pharm Bull (Tokyo) 2013; 61(4): 486-488.
[11]	Ghosh A, Pithadia, Bhat J, Bera S, Midya A, Fierke CA, Ramamoorthy A, Bhunia A. Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. Biochemistry 2015; 54(13): 2249-2261.
[12]	Martínez-Gualda B, Sun L, Martí-Marí O, Mirabelli C, Delang L, Neyts J, Schols D, Camarasa MJ, San-Félix A. Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum. Antiviral Research 2019; 168: 210-214.
[13]	Ahmed AMS, Abou-Elkhair RAI, El-Torky AM, Hassan AEA. 3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation. Nucleosides, Nucleotides and Nucleic Acids 2019; 38(8): 590-603.